title: Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Treatment of Acute Heart Failure.
abstract: OBJECTIVE
  To provide an evidence-based review of pharmacotherapies to treat acute heart failure. To accomplish this objective, we will discuss circulatory physiology, vasoactive agents, and their indications in the management of acute heart failure.
  
  
  METHODS
  A MEDLINE-baseline review of the literature.
  
  
  CONCLUSIONS
  The optimal selection of vasoactive agents requires a consideration of circulatory physiology and the tailored application of pharmacotherapies to treat patients with acute heart failure.
authors.affiliation: 1Department of Pediatrics, Baylor College of Medicine, Sections of Critical Care Medicine and Cardiology, Texas Children's Hospital, Houston, TX. 2Departments of Pediatrics and Critical Care Medicine, University of Toronto, the Hospital of Sick Children, Toronto, ON, Canada.
authors.forename: Sebastian C
authors.initials: SC
authors.lastname: Tume
authors.forename: Steven M
authors.initials: SM
authors.lastname: Schwartz
authors.forename: Ronald A
authors.initials: RA
authors.lastname: Bronicki
mesh_terms: D000208:Acute Disease; D002302:Cardiac Output / Q000187:drug effects; D002648:Child; D003325:Coronary Care Units; D003422:Critical Care / Q000592:standards*; D006330:Heart Defects, Congenital / Q000601:surgery; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D015278:Intensive Care Units, Pediatric / Q000592:standards